Drugs / Bioconjugate pneumococcal vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03303976 | Sep 2017 → Sep 2018 | bacterial pneumonia | LimmaTech Biologics AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bioconjugate pneumococcal vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03303976 ↗ |
| Modality | Vaccine | “new candidate vaccine against Streptococcus pneumoniae” NCT03303976 ↗ |
| Route | Intramuscular | “intramuscular injection monovalent bioconjugate pneumococcal vaccine” NCT03303976 ↗ |